Amalgamated Bank Sells 1,360 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Amalgamated Bank lessened its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 4.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 26,204 shares of the biotechnology company’s stock after selling 1,360 shares during the quarter. Amalgamated Bank’s holdings in Axon Enterprise were worth $6,769,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently made changes to their positions in the company. Sands Capital Management LLC raised its stake in Axon Enterprise by 31.1% in the 3rd quarter. Sands Capital Management LLC now owns 2,612,305 shares of the biotechnology company’s stock valued at $519,823,000 after acquiring an additional 619,179 shares during the period. Wellington Management Group LLP raised its holdings in Axon Enterprise by 3.3% during the 3rd quarter. Wellington Management Group LLP now owns 1,956,022 shares of the biotechnology company’s stock valued at $389,229,000 after acquiring an additional 62,324 shares during the period. Bank of New York Mellon Corp lifted its position in shares of Axon Enterprise by 28.3% during the third quarter. Bank of New York Mellon Corp now owns 726,400 shares of the biotechnology company’s stock worth $144,546,000 after acquiring an additional 160,359 shares in the last quarter. Westfield Capital Management Co. LP boosted its holdings in shares of Axon Enterprise by 184.3% in the third quarter. Westfield Capital Management Co. LP now owns 696,193 shares of the biotechnology company’s stock worth $138,535,000 after acquiring an additional 451,350 shares during the period. Finally, Northern Trust Corp boosted its holdings in shares of Axon Enterprise by 3.1% in the third quarter. Northern Trust Corp now owns 631,212 shares of the biotechnology company’s stock worth $125,605,000 after acquiring an additional 19,068 shares during the period. 79.08% of the stock is owned by hedge funds and other institutional investors.

Axon Enterprise Stock Performance

Axon Enterprise stock opened at $318.55 on Monday. The firm has a fifty day simple moving average of $308.83 and a two-hundred day simple moving average of $265.60. The company has a quick ratio of 2.66, a current ratio of 3.00 and a debt-to-equity ratio of 0.42. Axon Enterprise, Inc. has a twelve month low of $175.37 and a twelve month high of $329.87. The company has a market capitalization of $24.04 billion, a PE ratio of 138.50 and a beta of 0.91.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Tuesday, February 27th. The biotechnology company reported $0.77 earnings per share for the quarter, beating analysts’ consensus estimates of $0.48 by $0.29. Axon Enterprise had a return on equity of 14.11% and a net margin of 11.14%. The company had revenue of $432.14 million during the quarter, compared to analyst estimates of $418.97 million. Research analysts expect that Axon Enterprise, Inc. will post 2.44 EPS for the current year.

Analysts Set New Price Targets

AXON has been the topic of a number of recent research reports. JPMorgan Chase & Co. increased their price objective on Axon Enterprise from $330.00 to $365.00 and gave the stock an “overweight” rating in a report on Thursday, April 11th. Argus assumed coverage on shares of Axon Enterprise in a research report on Wednesday, March 13th. They issued a “buy” rating and a $380.00 price objective for the company. Needham & Company LLC reiterated a “buy” rating and issued a $400.00 target price on shares of Axon Enterprise in a research note on Wednesday, April 24th. Barclays raised their price target on shares of Axon Enterprise from $296.00 to $308.00 and gave the company an “overweight” rating in a report on Thursday, February 29th. Finally, The Goldman Sachs Group upped their price target on shares of Axon Enterprise from $297.00 to $339.00 and gave the stock a “buy” rating in a report on Wednesday, February 28th. Two equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $323.09.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.